Martin Ungerer

Title: Martin Ungerer: Innovator in Immunoadhesin Technology

Introduction

Martin Ungerer is a notable inventor based in Munich, Germany. He has made significant contributions to the field of immunology through his innovative work on immunoadhesins. With a total of two patents to his name, Ungerer is recognized for his advancements in fusion protein technology.

Latest Patents

Ungerer’s latest patents include a groundbreaking invention titled "Immunoadhesin comprising a glycoprotein VI domain." This invention provides a fusion protein that consists of the extracellular domain of glycoprotein VI, which is functional for binding to collagen, and the Fc domain of an immunoglobulin. The fusion protein is characterized by a specific polypeptide chain and is obtainable through a process that yields it in the form of a specific dimer. Another significant patent is "Polynucleotides encoding immunoadhesins comprising a glycoprotein VI domain," which similarly details a fusion protein with the same functional components and characteristics.

Career Highlights

Martin Ungerer is currently associated with Trigen GmbH, where he continues to push the boundaries of immunological research. His work has been instrumental in developing new therapeutic approaches that leverage the unique properties of glycoprotein VI.

Collaborations

Ungerer collaborates with esteemed colleagues such as Steffen Massberg and Meinrad Gawaz, who contribute to the innovative environment at Trigen GmbH. Their combined expertise fosters a dynamic research atmosphere that enhances the development of cutting-edge technologies.

Conclusion

Martin Ungerer stands out as a key figure in the field of immunoadhesin technology, with his patents paving the way for future advancements in immunology. His contributions are vital to the ongoing research and development in this important area of science.